CA Patent

CA3119729A1 — Synthesis of cannabigerol

Assigned to Treehouse Biotech Inc · Expires 2020-04-16 · 6y expired

What this patent protects

Multiple methods of synthesizing cannabigerol are presented. Combining olivetol with geraniol derivatives are provided. Cross-coupling methods of combing functionalized resorcinols are provided. Useful intermediates are formed during such cross-coupling steps.

USPTO Abstract

Multiple methods of synthesizing cannabigerol are presented. Combining olivetol with geraniol derivatives are provided. Cross-coupling methods of combing functionalized resorcinols are provided. Useful intermediates are formed during such cross-coupling steps.

Drugs covered by this patent

Patent Metadata

Patent number
CA3119729A1
Jurisdiction
CA
Classification
—
Expires
2020-04-16
Drug substance claim
No
Drug product claim
No
Assignee
Treehouse Biotech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.